The proteins of equid herpesvirus 1 (EHV 1) recognised by equine antisera and their ability to promote antibody-dependent cell-mediated cytotoxicity.

The article talks about an investigation into which proteins in Equid Herpesvirus-1 (EHV-1), a virus affecting horses, trigger our immune system to attack infected cells. It also looks at whether these proteins spur antibody-dependent cellular cytotoxicity (cell-killing action tied to antibodies), which could be crucial in forming a line of defense against this virus.

Objective and Methods

• The primary objective of this study presented in the article is to determine which proteins in EHV-1 are recognized by equine antiserum (a blood serum that contains antibodies against the virus) and the ability of these antibodies in the serum to promote ADCC.
• To identify these proteins, equine sera are used to immunoprecipitate (separate or isolate) virus-infected cell proteins. Immunoprecipitation is a technique that exploits the antigen-antibody interaction to isolate and concentrate a protein from a solution.
• After the immunoprecipitation, Polyacrylamide Gel Electrophoresis (PAGE), a method used for the separation of proteins based on their electrophoretic mobility, is used to identify specific viral proteins labeled as VP 2, 10a, 11, 13, 14, 15, 16, 20, 21, and 23a.

Examination of ADCC

• Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) is a mechanism of immune defense where the effector cells of the immune system actively lyse a cell, whose membrane-surface antigens (proteins) have been bound by specific antibodies. It is one of the ways the immune system can kill pathogen-infected cells.
• The researchers also examined the role of these immune serum in supporting ADCC in laboratory conditions – particularly cytotoxicity, or the quality of being toxic to cells, against two subtypes of the virus.
• The result showed that antibodies in the equine serum could perform cytotoxicity regardless of the specific strain of virus used for immunization. This suggests that irrespective of the strain, the antibodies are effective in recognizing and inducing an immune response against the virus-infected cells.

Implications of the Findings

• The study provides important insights into the immune response against EHV-1, especially on the proteins that trigger an immune response and the ability of these antibodies to induce ADCC.
• The findings might serve as the basis for future research into the development of targeted therapies or vaccines against EHV-1.